Fig. 8
From: S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1
The relationship between serum S100A8 level and clinicopathological features of breast cancers. (A) Histogram showing serum S100A8 level of patients with benign breast nodules and breast cancers. (B) Histogram showing the relationships between serum S100A8 level and tumor differentiation grade. (C–E) Histogram showing the relationships between serum S100A8 level and ER, PR, and Her2 status. (F) Histogram showing the relationships between serum S100A8 level and subtypes of breast cancers. ER: estrogen receptor; PR: progesterone receptor